cuprammonium cellulose

beta-2-microglobulin ; Homo sapiens







31 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 11818679 Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients. 2002 1
2 9347661 Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients. 1997 Sep 1
3 9506789 Beta2-microglobulin and IgE release during hemodialysis with cuprophan membrane. 1997 Dec 1
4 8887291 Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. 1996 Oct 1
5 7744517 Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis? 1994 Nov 1
6 8029157 [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis]. 1993 3
7 8399654 Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy. 1993 1
8 8465819 Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components. 1993 Apr 4
9 1942777 Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes. 1991 Aug 4
10 1992659 The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. 1991 Feb 2
11 2077409 Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes. 1990 1
12 2198890 Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis. 1990 6
13 2203684 Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes. 1990 Jan 1
14 2240054 Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. 1990 1
15 2264202 [Changes in the beta 2-microglobulin level during hemodialysis]. 1990 Sep-Oct 2
16 2266681 Effects of dialysis membranes on beta 2-microglobulin production and cellular expression. 1990 Nov 5
17 2269036 [Behavior of beta 2-microglobulin in patients undergoing blood purification]. 1990 Jun 1
18 2507977 Serum beta 2 microglobulin and extracellular fluid volume during haemodialysis. 1989 2
19 2509378 Red blood cell function and beta 2 microglobulin kinetics during cuprophan hemodialysis: a hypothesis. 1989 Oct 1
20 2646507 Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome. 1989 Mar 1
21 2651325 Clinical evaluation of a new high-flux cellulose acetate membrane. 1989 Feb 1
22 2655913 [Dialysis amyloidosis and beta-2-microglobulin]. 1989 Jan 13 1
23 2665936 [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?]. 1989 Apr 21 2
24 2722277 Radiological features of dialysis amyloid spondyloarthropathy. 1989 Apr 1
25 3055992 Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures. 1988 1
26 3058172 Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysis. 1988 Jul-Sep 3
27 3060434 Correlation of beta-2-microglobulin concentration changes to changes of distribution volume. 1988 Nov 1
28 3140102 Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies. 1988 2
29 3147418 Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane. 1988 1
30 3110692 Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility. 1987 2
31 3557275 [Statistical analyses on over ten years survivals in Hokkaido under chronic dialysis therapy]. 1986 Nov 1